Biotech

All Articles

Praxis epilepsy medicine decreases seizures in phase 2 trial

.Praxis Precision Medicines has actually scored yet another midphase succeed in epilepsy this year, ...

Three directors surrender as Dyne articles combined information for DMD prospect

.After leaving a scientific grip numerous years back, Dyne Therapeutics has exposed new stage 1/2 in...

Arrowhead fires off period 3 records in uncommon metabolic ailment in front of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its give ahead of a potential showdown with Ionis, publishi...

Pfizer, Valneva present lyme illness go efficient for 2nd booster

.Pfizer and Valneva might possess about two even more years to wait just before they make the very f...

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's study a discussion along with Ayla Ellison, Tough Biotech Editor-in-Chief as well as Michelle...

New information demonstrate how Bayer's asundexian stopped working to prevent movements

.Bayer suspended the phase 3 trial for its aspect XIa prevention asundexian behind time in 2015 afte...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its own various sclerosis (MS) med tolebrutinib to the FD...

Galapagos' stockpile as fund presents intent to shape its progression

.Galapagos is actually coming under additional pressure coming from capitalists. Having developed a ...

Cell- concentrated Sana scoops 1st CSO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings an...

Allist pays Jacobio $21M, landing job in Chinese KRAS ethnicity

.Shanghai Allist Pharmaceuticals has acquired on its own a starring job in China's KRAS market, payi...